556 related articles for article (PubMed ID: 17556601)
1. The risk of malarial infections and disease in Papua New Guinean children.
Michon P; Cole-Tobian JL; Dabod E; Schoepflin S; Igu J; Susapu M; Tarongka N; Zimmerman PA; Reeder JC; Beeson JG; Schofield L; King CL; Mueller I
Am J Trop Med Hyg; 2007 Jun; 76(6):997-1008. PubMed ID: 17556601
[TBL] [Abstract][Full Text] [Related]
2. Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.
Betuela I; Rosanas-Urgell A; Kiniboro B; Stanisic DI; Samol L; de Lazzari E; Del Portillo HA; Siba P; Alonso PL; Bassat Q; Mueller I
J Infect Dis; 2012 Dec; 206(11):1771-80. PubMed ID: 22966124
[TBL] [Abstract][Full Text] [Related]
3. Genetic diversity and dynamics of plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea.
Bruce MC; Galinski MR; Barnwell JW; Donnelly CA; Walmsley M; Alpers MP; Walliker D; Day KP
Parasitology; 2000 Sep; 121 ( Pt 3)():257-72. PubMed ID: 11085246
[TBL] [Abstract][Full Text] [Related]
4. Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study.
Laman M; Benjamin JM; Moore BR; Salib M; Tawat S; Davis WA; Siba PM; Robinson LJ; Davis TM
Malar J; 2015 Mar; 14():121. PubMed ID: 25889150
[TBL] [Abstract][Full Text] [Related]
5. Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.
Cole-Tobian JL; Michon P; Biasor M; Richards JS; Beeson JG; Mueller I; King CL
Infect Immun; 2009 Sep; 77(9):4009-17. PubMed ID: 19564376
[TBL] [Abstract][Full Text] [Related]
6. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
7. Lack of associations of α(+)-thalassemia with the risk of Plasmodium falciparum and Plasmodium vivax infection and disease in a cohort of children aged 3-21 months from Papua New Guinea.
Rosanas-Urgell A; Senn N; Rarau P; Aponte JJ; Reeder JC; Siba PM; Michon P; Mueller I
Int J Parasitol; 2012 Nov; 42(12):1107-13. PubMed ID: 23085147
[TBL] [Abstract][Full Text] [Related]
8. Anti-malarial seroprevalence assessment during an elimination programme in Chabahar District, south-eastern Iran.
Zakeri S; van den Hoogen LL; Mehrizi AA; Karimi F; Raeisi A; Drakeley C
Malar J; 2016 Jul; 15(1):382. PubMed ID: 27448606
[TBL] [Abstract][Full Text] [Related]
9. Antibody Responses to
McLean ARD; Boel M; McGready R; Ataide R; Drew D; Tsuboi T; Beeson JG; Nosten F; Simpson JA; Fowkes FJI
Am J Trop Med Hyg; 2017 May; 96(5):1197-1204. PubMed ID: 28500806
[TBL] [Abstract][Full Text] [Related]
10. IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.
França CT; Li Wai Suen CSN; Carmagnac A; Lin E; Kiniboro B; Siba P; Schofield L; Mueller I
Malar J; 2017 Sep; 16(1):386. PubMed ID: 28946883
[TBL] [Abstract][Full Text] [Related]
11. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
[TBL] [Abstract][Full Text] [Related]
12. Unexpected high circulation of Plasmodium vivax in asymptomatic children from Kédougou, southeastern Senegal.
Niang M; Diop F; Niang O; Sadio BD; Sow A; Faye O; Diallo M; Sall AA; Perraut R; Toure-Balde A
Malar J; 2017 Dec; 16(1):497. PubMed ID: 29284488
[TBL] [Abstract][Full Text] [Related]
13. Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children.
Lin E; Kiniboro B; Gray L; Dobbie S; Robinson L; Laumaea A; Schöpflin S; Stanisic D; Betuela I; Blood-Zikursh M; Siba P; Felger I; Schofield L; Zimmerman P; Mueller I
PLoS One; 2010 Feb; 5(2):e9047. PubMed ID: 20140220
[TBL] [Abstract][Full Text] [Related]
14. Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea.
Karunajeewa HA; Kemiki A; Alpers MP; Lorry K; Batty KT; Ilett KF; Davis TM
Pediatr Infect Dis J; 2003 Mar; 22(3):251-6. PubMed ID: 12634587
[TBL] [Abstract][Full Text] [Related]
15. Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea.
Koepfli C; Robinson LJ; Rarau P; Salib M; Sambale N; Wampfler R; Betuela I; Nuitragool W; Barry AE; Siba P; Felger I; Mueller I
PLoS One; 2015; 10(5):e0126747. PubMed ID: 25996916
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria.
Karl S; Laman M; Moore BR; Benjamin JM; Salib M; Lorry L; Maripal S; Siba P; Robinson LJ; Mueller I; Davis TM
Acta Trop; 2016 Aug; 160():1-8. PubMed ID: 27056132
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil.
Cerutti C; Boulos M; Coutinho AF; Hatab Mdo C; Falqueto A; Rezende HR; Duarte AM; Collins W; Malafronte RS
Malar J; 2007 Mar; 6():33. PubMed ID: 17371598
[TBL] [Abstract][Full Text] [Related]
18. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity.
Collins WE; Jeffery GM
Am J Trop Med Hyg; 1999 Jul; 61(1 Suppl):36-43. PubMed ID: 10432043
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children.
Ome-Kaius M; Kattenberg JH; Zaloumis S; Siba M; Kiniboro B; Jally S; Razook Z; Mantila D; Sui D; Ginny J; Rosanas-Urgell A; Karl S; Obadia T; Barry A; Rogerson SJ; Laman M; Tisch D; Felger I; Kazura JW; Mueller I; Robinson LJ
BMC Med; 2019 Dec; 17(1):220. PubMed ID: 31813381
[TBL] [Abstract][Full Text] [Related]
20. Identification of different malaria patterns due to Plasmodium falciparum and Plasmodium vivax in Ethiopian children: a prospective cohort study.
Seyoum D; Kifle YG; Rondeau V; Yewhalaw D; Duchateau L; Rosas-Aguirre A; Speybroeck N
Malar J; 2016 Apr; 15():208. PubMed ID: 27075667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
